Drug-eluting stents

Author Interview

Serial Assessment of Coronary Artery Healing of a Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months by Optical Coherence Tomography (OCT)—The REPAIR Trial: An Interview With J. Ribamar Costa, Jr, MD, PhD

04/04/2024

J. Ribamar Costa, Jr, MD, PhD

Dr Deepak L. Bhatt catches up with Dr J. Ribamar Costa about his Editor’s 2023 Top 10 article, “Serial Assessment of Coronary Artery Healing of a Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months by Optical Coherence Tomography...

Dr Deepak L. Bhatt catches up...

04/04/2024

Journal of Invasive Cardiology

Original Contribution

Serial Assessment of Coronary Artery Healing of a Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months by Optical Coherence Tomography (OCT)—The REPAIR Trial

05/01/2023

Fausto Feres , MD, PhD;

Guilherme V. Silva , MD;

Andre Manica , MD;

Rafael A. Meneguz-Moreno , MD, PhD;

J. Ribamar Costa Jr., MD, PhD;

Daniel Chamié , MD, PhD;

Jose Airton Arruda , MD, PhD;

George D. Dangas , MD, PhD;

Amanda G.R.M. Sousa , MD, PhD;

Ricardo A. Costa , MD, PhD;

In this study, the authors assessed the vessel-healing pattern of the sirolimus-eluting Inspiron DES using serial optical coherence tomography, assuming that this thin-strut, biodegradable-polymer DES promotes a faster healing.

In this study, the authors...

05/01/2023

Journal of Invasive Cardiology

Interview

Two-Year Results of the ILLUMINA Study: An Interview With Andrea Kahlberg, MD

01/19/2023

Andrea Kahlberg , MD;

VDM speaks with Dr. Andrea Kahlberg to discuss the 2-year results of the ILLUMINA study.

VDM speaks with Dr. Andrea...

01/19/2023

Vascular Disease Management

des Plantes Polymer-Coated Stents Figure 1

Original Contribution

Procedural Performance of Ultrathin, Biodegradable Polymer-Coated Stents Versus Durable Polymer-Coated Stents Based on Intracoronary Imaging

11/01/2022

Maria N. Tovar Forero , MD;

Leon Visser , BSc;

Alessandra Scoccia , MD;

Eric Boersma , PhD;

Tara Neleman , BSc;

Rutger-Jan Nuis , MD, PhD;

Frederik T.W. Groenland , MD;

Wijnand K. den Dekker , MD, PhD;

Jurgen M.R. Ligthart , RT, BSc;

Jeroen Wilschut , MD;

Nicolas M. Van Mieghem , MD, PhD;

Roberto Diletti , MD, PhD;

Joost Daemen , MD, PhD;

Felix Zijlstra , MD, PhD;

Thinner stent struts might lead to a higher risk of recoil and subsequently a smaller minimal stent area (MSA), which is known to be the strongest predictor of stent failure. We compared procedural performance between an ultrathin-strut...

Thinner stent struts might lead...

11/01/2022

Journal of Invasive Cardiology

Original Contribution

Efficacy and Safety of 3 Versus 6 Months of Dual-Antiplatelet Therapy in Patients Implanted With Coroflex ISAR Stents: A Prospective, Multicenter, Randomized Clinical Trial

07/22/2022

Seung-Woon Rha , MD, PhD;

Joon-Han Shin , MD;

Woong Chol Kang , MD;

Seung-Jea Tahk , MD, PhD;

Sang-Yong Yoo , MD;

Woo-Young Chung , MD, PhD;

Chi-Hoon Kim , MD;

Ki-Bum Won , MD;

Wook Bum Pyun , MD, PhD;

Jae Sik Jang , MD, PhD;

Moo-Hyun Kim , MD, PhD;

Uram Jin , MD;

Soon Jun Hong , MD;

So-Yeon Choi , MD, PhD;

Yun-Seok Choi , MD;

Kyoung-Woo Seo , MD;

Hee-Yeol Kim , MD;

Hyoung-Mo Yang , MD, PhD;

Rak Kyeong Choi , MD, PhD;

Hong-Seok Lim , MD, PhD;

Eun Joo Cho , MD, PhD;

Sung Yun Lee , MD, PhD;

Byoung-Joo Choi , MD;

Young Joon Hong , MD;

Myeong-Ho Yoon , MD, PhD;

This study examined the efficacy and safety of 3- versus 6-month DAPT in patients implanted with Coroflex ISAR polymer-free DESs.

This study examined the efficacy...

07/22/2022

Journal of Invasive Cardiology

Original Contribution

Feasibility and Clinical Outcomes of 48 mm Drug-Eluting Stents in the Management of Patients With Coronary Artery Disease

12/01/2021

Ahmed Mahmoud El Amrawy , MD;

Mohamed Ibrahim Loutfi , MD;

Salah Mohamed El Tahan , MD;

Sherif Wagdy Ayad , MD;

The study goal was to assess the feasibility and short-term clinical outcomes of implanting 48 mm drug-eluting stents (DESs) for the treatment of long lesions in patients with coronary artery disease (CAD).

The study goal was to assess the...

12/01/2021

Journal of Invasive Cardiology

Commentary

The Paclitaxel-Coated Conundrum: A Commentary Article

01/14/2020

Michael Patel , MD;

Robert E. Beasley , MD, FSCAI, FSIR;

Michael Patel, MD, and Robert Beasley, MD discuss drug-eluting stents and drug-coated balloons.

Michael Patel, MD, and Robert...

01/14/2020

Vascular Disease Management

Calcium Corner

Two-Year Results of IMPERIAL: First-Ever Randomized Study of Eluvia and Zilver PTX in Femoropopliteal Artery Lesions

01/01/2020

William A. Gray , MD, FACC, FSCAI;

The Eluvia stent utilizes a drug-polymer combination that provides a sustained release of paclitaxel over one year.

The Eluvia stent utilizes a...

01/01/2020

Cath Lab Digest

FDA Panel

The Future is Going to Be Drug-Coated or Drug-Eluting. We Need Individual Patient Data to Move Forward.

06/27/2019

Konstantinos Katsanos , MSc, MD, PhD;

VDM talks with Konstantinos Katsanos, MSc, MD, PhD, EBIR, Assistant Professor, Interventional Radiology, School of Medicine, Patras University Hospital, Patras, Greece.

VDM talks with Konstantinos...

06/27/2019

Vascular Disease Management

Clinical and Industry News

BIOTRONIK Debuts Orsiro on US Market at CRT 2019 With New Data From BIO-RESORT, Meta-Analysis and Health Economic Evaluation

03/06/2019

BIO-RESORT RCT Three-Year Data Analysis Shows a Consistent Trend Towards Lower Target Vessel Failure Rates for Orsiro Compared to Resolute Integrity and Synergy Washington, D.C. and BUELACH, Switzerland, March 6, 2019 – Three-year outcome...

BIO-RESORT RCT Three-Year Data...

03/06/2019

Cath Lab Digest